NCT05703542 2025-07-18BXCL701 Phase 1 R/R Acute Myeloid Leukemia or Myelodysplastic SyndromeDana-Farber Cancer InstitutePhase 1 Recruiting24 enrolled
NCT00086203 2015-03-25Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)FDA Office of Orphan Products DevelopmentPhase 2 Completed